Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Anesthesia and Analgesia

Volume  5, Issue 4, April 2018, Pages 618-622
 

Original Article

A Randomized Clinical Trail to Compare Palonosetron and Ondansetron for Prevention of Post Operative Nausea and Vomiting

Shilpa Masur1, Dinesh Naik2, Abhishek H.N.3, Vandana Gogate4

1Assistant Professor 2Assistant Professor 3Post Graduate 4Professor, Dept. of Anesthesia, S.N Medical College, Navanagar, Bagalkot, Karnataka 587102, India.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.5418.18

Abstract

Abstract: Nausea and vomiting is known to be associated with the use of anaesthetic technique for many years. Ondansetron a gold standard drug used for treatment of post operative nausea and vomiting (PONV) is short acting and multiple doses are needed. Objective of the present study is to compare the efficacy of palonosetron and ondansetron for prevention of PONV in patients undergoing abdominal surgery under general anaesthesia.

Methods: 140 patients undergoing abdominal surgery under general anesthesia were randomised and allocated into two groups after taking into consideration inclusion and exclusion criteria. Group I received ondansetron 8mg intravenously and Group II received palonosetron 0.075mg intravenously 5 min before the induction of anesthesia. In all patients general anaesthesia given using thiopentone as inducing agent. Occurrence of PONV was noted and was scored for 24 hrs.

Results: The incidence of PONV was significantly lower in the palonosetron group compared with the ondansetron group (24.3% vs 78.6%, respectively). Emetic episodes were observed in 5.71% of patients in palonosetron group compared to 61.4% of patients in ondansetron group (P value <0.001). The results were clinically and statistically significant.

Conclusion: Incidence of PONV and emetic episodes is less in patients who had received palonosetron in comparison to those who had received ondansetron. From the study we conclude that palonosetron is more efficacious than ondansetron for prevention of PONV in patients undergoing abdominal surgery under general anesthesia.

 

 


Keywords : Post Operative Nausea and Vomiting; Palonosetron; Ondansetron; General Anaesthesia. 
Corresponding Author : Dinesh Naik, Assistant Professor, Dept. of Anesthesia, S.N Medical College, Navanagar, Bagalkot, Karnataka 587102, India.